ConductScience.org, home

Paper31366609

8-Aminoquinoline Therapy for Latent Malaria.

Baird JK. Clin Microbiol Rev, 2019. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. 8-Aminoquinoline Therapy for Latent Malaria. Papers, record 31366609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31366609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
8-Aminoquinoline Therapy for Latent Malaria.
PubMed
Journal
Clin Microbiol Rev
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
5.27
iCite
Revised in PubMed
2024-07-30
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baird JKJ Kevin

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminoquinolinesMajor topic
MalariaMajor topic
Antimalarials
Humans

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed
106680/Z/14/ZWellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References244

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
211425182The neglected burden of Plasmodium vivax malaria.Am J Trop Med Hyg2001https://conductscience.org/library/papers/11425182PubMed
44386875Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency.Blood1968https://conductscience.org/library/papers/4386875PubMed
520133198Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination.Trends Parasitol2010https://conductscience.org/library/papers/20133198PubMed
66976854New tissue schizontocidal antimalarial drugs.Bull World Health Organ1981https://conductscience.org/library/papers/6976854PubMed
722900786Primaquine radical cure of Plasmodium vivax: a critical review of the literature.Malar J2012https://conductscience.org/library/papers/22900786PubMed
8828446The quartan malarial nephrotic syndrome.Adv Nephrol Necker Hosp1976https://conductscience.org/library/papers/828446PubMed
94391843Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals.Ann N Y Acad Sci1968https://conductscience.org/library/papers/4391843PubMed
1022144436Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations.Am J Trop Med Hyg2011https://conductscience.org/library/papers/22144436PubMed
1126610844Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries.Malar J2015https://conductscience.org/library/papers/26610844PubMed
1231229233Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study.Lancet2019https://conductscience.org/library/papers/31229233PubMed
1328850568Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study.PLoS Med2017https://conductscience.org/library/papers/28850568PubMed
1430103751
Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
Malar J2018https://conductscience.org/library/papers/30103751PubMed
1530085149Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs.J Antimicrob Chemother2018https://conductscience.org/library/papers/30085149PubMed
1727672207Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.Am J Trop Med Hyg2016https://conductscience.org/library/papers/27672207PubMed
1824853873First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.PLoS One2014https://conductscience.org/library/papers/24853873PubMed
1919209263Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki.Ther Clin Risk Manag2008https://conductscience.org/library/papers/19209263PubMed
2024901334A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings.PLoS Negl Trop Dis2014https://conductscience.org/library/papers/24901334PubMed
224250858Primaquine induced haemolysis in G-6-PD deficient Burmese.Trans R Soc Trop Med Hyg1970https://conductscience.org/library/papers/4250858PubMed
2327601524High Efficacy of Primaquine Treatment for Plasmodium vivax in Western Thailand.Am J Trop Med Hyg2016https://conductscience.org/library/papers/27601524PubMed
2416020691Plasmodium ovale: parasite and disease.Clin Microbiol Rev2005https://conductscience.org/library/papers/16020691PubMed

See all 244 referencesDownload CSV of references

Cited by83

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
42922745Parasite and host factors associated with malaria parasite liver stage latency.Res Sq2026https://conductscience.org/library/papers/42922745PubMed
42761215Analytical dilemmas in assessing efficacy of radical cure of vivax malaria.Lancet Reg Health Southeast Asia2026https://conductscience.org/library/papers/42761215PubMed
42653783Revisiting Glutathione Transferases of Plasmodium as Potential Targets for Coadjuvant Therapies and the Development of New Antimalarials.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653783PubMed
42188870Tafenoquine: A Breakthrough Option for Babesiosis Treatment.Trop Med Infect Dis2026https://conductscience.org/library/papers/42188870PubMed
41980931Potent acridone antimalarial against all three life stages of Plasmodium.Nat Commun2026https://conductscience.org/library/papers/41980931PubMed
41953713G6PD deficiency in Indonesia: a systematic review and update of prevalence and variant maps in the context of malaria elimination.Lancet Reg Health West Pac2026https://conductscience.org/library/papers/41953713PubMed
41625564Plasmodium vivax elimination from India may need therapeutic efficacy studies - Informed shift to artemisinin-based treatment.IJID Reg2026https://conductscience.org/library/papers/41625564PubMed
41361889Haematologic responses to primaquine used for radical cure of Plasmodium vivax in public health facilities in Ethiopia: a prospective observational study.Malar J2025https://conductscience.org/library/papers/41361889PubMed
41088393FocaL mass drug administration for Plasmodium vivax malaria elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru.Trials2025https://conductscience.org/library/papers/41088393PubMed
41025349A drug repurposing approach reveals targetable epigenetic pathways in Plasmodium vivax hypnozoites.Elife2025https://conductscience.org/library/papers/41025349PubMed
40827872How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil.J Infect Dis2025https://conductscience.org/library/papers/40827872PubMed
40799291Molecular Mechanisms of Drug-Induced Hemolysis in G6PD Deficiency: Mechanistic Insights.Oxid Med Cell Longev2025https://conductscience.org/library/papers/40799291PubMed
40764298Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages.Nat Commun2025https://conductscience.org/library/papers/40764298PubMed
40179277Development of Next-Generation Antimalarial Acridones with Radical Cure Potential.J Med Chem2025https://conductscience.org/library/papers/40179277PubMed
40152241Radical Cure of Plasmodium vivax With Primaquine and CYP2D6 Polymorphism in Southeast Asia.Clin Infect Dis2025https://conductscience.org/library/papers/40152241PubMed
39992119Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/39992119PubMed
39639330Human liver organoids are susceptible to Plasmodium vivax infection.Malar J2024https://conductscience.org/library/papers/39639330PubMed
39339162Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies.Pharmaceutics2024https://conductscience.org/library/papers/39339162PubMed
39332427Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.Lancet Child Adolesc Health2024https://conductscience.org/library/papers/39332427PubMed
39331646Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.PLoS Med2024https://conductscience.org/library/papers/39331646PubMed

See all 83 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31366609

GET https://conductscience.org/api/papers/v1/31366609/references?page=2